Index of reports
> Death (161)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ribavirin death. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 161 Next >>
Possible Ribavirin side effects in 47 year old female
Reported by a health professional (non-physician/pharmacist) from Morocco on 2012-08-23
Patient: 47 year old female
Reactions: Weight Decreased, Angiotensin Converting Enzyme Increased, Subcutaneous Nodule, Aphasia, Coma, Viith Nerve Paralysis, Brain Oedema, Sarcoidosis, Acute Respiratory Failure, Lethargy, Dyspnoea, Neurological Decompensation, Lung Neoplasm, Sensation of Heaviness, Rash, Granuloma, Lymphadenopathy Mediastinal, Cerebral Sarcoidosis, Pleocytosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Peginterferon Alfa-2A
Dosage: 180 ug, once a week
Ribavirin
Dosage: 400 mg, bid
Indication: Hepatitis C
Other drugs received by patient: Prednisolone; Prednisolone; Methylprednisolone
Possible Ribavirin side effects in
Reported by a consumer/non-health professional from Brazil on 2012-08-23
Patient:
Reactions: Pneumonia, Nausea, Drug Ineffective, Urine Output Decreased, Headache, Varices Oesophageal, Diarrhoea, Blood Pressure Inadequately Controlled, Upper Gastrointestinal Haemorrhage, Septic Shock, Acute Respiratory Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Ribavirin
Dosage: unk
Victrelis
Dosage: unk
Start date: 2012-02-01
Other drugs received by patient: Interferon (Unspecified)
Possible Ribavirin side effects in
Reported by a consumer/non-health professional from Germany on 2012-08-22
Patient:
Reactions: Hepatorenal Syndrome, Sepsis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Citalopram Hydrobromide
Peginterferon Alfa-2A
Dosage: 180 microgram, qw
Indication: Hepatitis C
Start date: 2012-01-05
Ribavirin
Dosage: 800 mg, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-05
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-02
Possible Ribavirin side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20
Patient: male
Reactions: Abdominal Pain, Dyspnoea, Ileus
Adverse event resulted in: death
Drug(s) suspected as cause:
Cozaar
Indication: Product Used FOR Unknown Indication
Pegasys
Indication: Product Used FOR Unknown Indication
Ribavirin
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Incivek
Possible Ribavirin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20
Patient:
Reactions: Anaemia, Cerebrovascular Accident
Adverse event resulted in: death
Drug(s) suspected as cause:
Pegasys
Indication: Product Used FOR Unknown Indication
Ribavirin
Indication: Product Used FOR Unknown Indication
Possible Ribavirin side effects in
Reported by a individual with unspecified qualification from Korea, Republic of on 2012-08-15
Patient:
Reactions: Major Depression
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Boceprevir
Dosage: 12 df, tid
Administration route: Oral
Start date: 2012-05-03
End date: 2012-05-30
Boceprevir
Dosage: 12 df, tid
Administration route: Oral
Start date: 2012-05-03
End date: 2012-05-30
Boceprevir
Dosage: 12 df, tid
Administration route: Oral
Start date: 2012-05-03
End date: 2012-05-30
Boceprevir
Dosage: 12 df, tid
Administration route: Oral
Start date: 2012-05-03
End date: 2012-05-30
PEG-Intron
Dosage: 1 df, qw
Indication: Hepatitis C
Start date: 2012-04-05
End date: 2012-05-30
Ribavirin
Dosage: 5 df, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-05
End date: 2012-05-30
Ribavirin
Dosage: 5 df, bid
Administration route: Oral
Start date: 2012-04-05
End date: 2012-05-30
Possible Ribavirin side effects in
Reported by a physician from United States on 2012-08-13
Patient:
Reactions: Pancreatitis
Adverse event resulted in: death
Drug(s) suspected as cause:
Incivek
Indication: Hepatitis C
Pegasys
Indication: Hepatitis C
Ribavirin
Indication: Hepatitis C
Possible Ribavirin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: Abdominal Pain, Dyspnoea, Ileus
Adverse event resulted in: death
Drug(s) suspected as cause:
Cozaar
Indication: Product Used FOR Unknown Indication
Pegasys
Indication: Product Used FOR Unknown Indication
Ribavirin
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Telaprevir
Possible Ribavirin side effects in female
Reported by a physician from United States on 2012-08-10
Patient: female, weighing 115.0 kg (253.0 pounds)
Reactions: Multi-Organ Failure, Emphysematous Cystitis, Urinary Tract Infection, Sepsis, Ascites
Adverse event resulted in: death
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2010-12-23
End date: 2011-01-13
Pegasys
Start date: 2010-11-05
Ribavirin
Indication: Hepatitis C
Start date: 2010-11-05
Other drugs received by patient: Lisinopril; Glipizide; Fluoxetine HCL; Spironolactone; Propranolol; Omeprazole; Glipizide; Fosamax
Possible Ribavirin side effects in
Reported by a physician from Germany on 2012-08-09
Patient:
Reactions: Mallory-Weiss Syndrome, Bile Duct Stent Insertion, Peritonitis Bacterial, Bile Duct Stone, Hepatic Neoplasm Malignant, Portal Vein Thrombosis, Cholecystitis, Hepatic Cirrhosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ferrous Sulfate TAB
Dosage: 100 mg, qd
Administration route: Oral
Indication: Iron Deficiency
Start date: 2010-11-01
Peginterferon Alfa-2B
Dosage: 105 microgram, qw
Indication: Hepatitis C
Start date: 2011-03-18
End date: 2012-02-17
Ribavirin
Dosage: 1000 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-03-18
End date: 2011-12-31
Ribavirin
Dosage: 1000 mg, qd
Administration route: Oral
Start date: 2012-01-03
End date: 2012-02-17
Other drugs received by patient: Enoxaparin Sodium; Pantoprazole; Hepa-Merz; Dipyrone INJ; Humatin
Possible Ribavirin side effects in male
Reported by a individual with unspecified qualification from France on 2012-08-09
Patient: male, weighing 61.0 kg (134.2 pounds)
Reactions: Tooth Disorder
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
PEG-Intron
Dosage: 30 ?g, qw
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Peginterferon Alfa-2B
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Peginterferon Alfa-2B
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Placebo
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Placebo
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Ribavirin
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Ribavirin
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Possible Ribavirin side effects in 50 year old
Reported by a physician from Germany on 2012-08-08
Patient: 50 year old
Reactions: Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Peginterferon Alfa-2A
Indication: Hepatitis C
Ribavirin
Indication: Hepatitis C
Possible Ribavirin side effects in female
Reported by a physician from Germany on 2012-08-06
Patient: female
Reactions: Intestinal Ischaemia, Anaemia
Adverse event resulted in: death
Drug(s) suspected as cause:
Peginterferon Alfa-2A
Indication: Hepatitis C
Ribavirin
Indication: Hepatitis C
Possible Ribavirin side effects in
Reported by a individual with unspecified qualification from France on 2012-08-03
Patient:
Reactions: Lung Disorder, Haemolytic Anaemia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Boceprevir
Dosage: 800 mg, tid
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-06-22
Neorecormon
Dosage: 30000 iu, biw
Indication: Anaemia
Start date: 2012-04-26
End date: 2012-06-22
Peginterferon Alfa-2B
Dosage: 80 ?g, qw
Indication: Hepatitis C
Start date: 2012-03-16
End date: 2012-06-22
Ribavirin
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2012-03-16
End date: 2012-06-22
Ribavirin
Dosage: 600 mg, qd
Start date: 2012-06-07
Ribavirin
Dosage: 400 mg, qd
Start date: 2012-06-20
Other drugs received by patient: Acetaminophen; Isentress; Raltegravir; Raltegravir; Acetaminophen; Emtriva; Celluvisc; Carbohydrates (Unspecified) (+) FAT (Unspecified) (+) Minerals (Unspec; Viread; Mycoster; Carbohydrates (Unspecified) (+) FAT (Unspecified) (+) Minerals (Unspec; Emtriva; Viread; Mycoster; Celluvisc; Drospirenone and Ethinyl Estradiol; Drospirenone and Ethinyl Estradiol; Dexeryl Tablets; Dexeryl Tablets
Possible Ribavirin side effects in
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-02
Patient:
Reactions: Confusional State, Anaemia, Ketoacidosis, Ascites, Loss of Consciousness, Haemoglobin Decreased, Multi-Organ Failure, Renal Failure, Platelet Count Decreased, Septic Shock, Blood Glucose Increased
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Pegasys
Dosage: 180 ?g, qw
Indication: Hepatitis C
Start date: 2011-11-07
End date: 2012-03-13
Ribavirin
Dosage: 1000 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-07
End date: 2012-03-13
Victrelis
Dosage: 800 mg, q8h
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-05
End date: 2012-03-13
Other drugs received by patient: Glyburide; Metformin Hydrochloride; Eprex; Nadolol; Diazepam; Spironolactone; Lasix
Possible Ribavirin side effects in
Reported by a consumer/non-health professional from Brazil on 2012-08-02
Patient:
Reactions: Foetal Exposure During Pregnancy, Cardiac Operation, Heart Disease Congenital
Adverse event resulted in: death
Drug(s) suspected as cause:
Ribavirin
Other drugs received by patient: Pegasys; Lisador; Dramin
Possible Ribavirin side effects in 57 year old male
Reported by a physician from United States on 2012-07-31
Patient: 57 year old male
Reactions: Death, Tubulointerstitial Nephritis, Renal Failure, Sepsis, Rash
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Allopurinol
Indication: Hepatitis C
Pegasys
Indication: Hepatitis C
Ribavirin
Indication: Hepatitis C
Telaprevir
Indication: Hepatitis C
Possible Ribavirin side effects in male
Reported by a physician from United States on 2012-07-30
Patient: male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2011-07-08
End date: 2011-09-01
Ribavirin
Dosage: 600 mg once and 400 mg once
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-07-08
End date: 2011-09-01
Possible Ribavirin side effects in
Reported by a physician from Germany on 2012-07-27
Patient:
Reactions: Mallory-Weiss Syndrome, Bile Duct Stent Insertion, Peritonitis Bacterial, Bile Duct Stone, Hepatic Neoplasm Malignant, Portal Vein Thrombosis, Cholecystitis, Hepatic Cirrhosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ferrous Sulfate TAB
Dosage: 100 mg, qd
Administration route: Oral
Indication: Iron Deficiency
Start date: 2010-11-01
Peginterferon Alfa-2B
Dosage: 105 microgram, qw
Indication: Hepatitis C
Start date: 2011-03-18
End date: 2012-02-17
Ribavirin
Dosage: 1000 mg, qd
Administration route: Oral
Start date: 2012-01-03
End date: 2012-02-17
Ribavirin
Dosage: 1000 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-03-18
End date: 2011-12-31
Other drugs received by patient: Pantoprazole; Dipyrone INJ; Humatin; Hepa-Merz; Enoxaparin Sodium
Possible Ribavirin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27
Patient:
Reactions: Haematochezia, Haemoglobin Decreased, Abdominal Discomfort, Fatigue, RED Blood Cell Count Decreased, Haemorrhoids, Flatulence, Platelet Count Decreased, Memory Impairment, Blood Pressure Decreased, Abdominal Pain Upper, Faeces Discoloured
Adverse event resulted in: death
Drug(s) suspected as cause:
Ribavirin
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-05-14
Victrelis
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-06-11
Other drugs received by patient: Pegasys
Possible Ribavirin side effects in
Reported by a individual with unspecified qualification from France on 2012-07-26
Patient:
Reactions: Tooth Disorder
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
PEG-Intron
Dosage: 30 ?g, qw
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Peginterferon Alfa-2B
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Placebo
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Ribavirin
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Possible Ribavirin side effects in
Reported by a individual with unspecified qualification from Germany on 2012-07-25
Patient:
Reactions: Bile Duct Stent Insertion, Mallory-Weiss Syndrome, Hepatic Neoplasm Malignant, Peritonitis Bacterial, Bile Duct Stone, Portal Vein Thrombosis, Cholecystitis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ferrous Sulfate TAB
Dosage: 100 mg, qd
Administration route: Oral
Indication: Iron Deficiency
Start date: 2010-11-01
Peginterferon Alfa-2B
Dosage: 105 microgram, qw
Indication: Hepatitis C
Start date: 2011-03-18
End date: 2012-02-17
Ribavirin
Dosage: 1000 mg, qd
Administration route: Oral
Start date: 2012-01-03
End date: 2012-02-17
Ribavirin
Dosage: 1000 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-03-18
End date: 2011-12-31
Other drugs received by patient: Pantoprazole; Enoxaparin Sodium; Dipyrone INJ
Possible Ribavirin side effects in
Reported by a individual with unspecified qualification from France on 2012-07-25
Patient:
Reactions: Pyelonephritis Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Boceprevir
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-07
Peginterferon Alfa-2B
Dosage: 80 microgram, qw
Indication: Hepatitis C
Start date: 2012-02-08
Ribavirin
Dosage: 400 mg, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-08
Other drugs received by patient: Isentress; Truvada; Truvada; Isentress
Possible Ribavirin side effects in male
Reported by a physician from Mexico on 2012-07-23
Patient: male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Ribavirin
Indication: Hepatitis C
Possible Ribavirin side effects in
Reported by a consumer/non-health professional from United States on 2012-07-20
Patient:
Reactions: Hypogeusia, Glossodynia, Tinnitus, Hypoaesthesia Oral
Adverse event resulted in: death
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Ribavirin
Indication: Hepatitis C
Victrelis
Dosage: 800 mg, q8h
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-11
Possible Ribavirin side effects in male
Reported by a physician from Mexico on 2012-07-19
Patient: male
Reactions: Gastrointestinal Haemorrhage
Adverse event resulted in: death
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Ribavirin
Indication: Hepatitis C
Possible Ribavirin side effects in 62 year old male
Reported by a pharmacist from United States on 2012-07-19
Patient: 62 year old male, weighing 76.0 kg (167.2 pounds)
Reactions: Interstitial Lung Disease, Respiratory Failure, Condition Aggravated
Adverse event resulted in: death
Drug(s) suspected as cause:
Peginterferon Alfa-2A
Dosage: 180 ml qweek sq
Indication: Hepatitis C
Start date: 2012-01-03
End date: 2012-05-10
Ribavirin
Dosage: mg po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-03
End date: 2012-05-10
Possible Ribavirin side effects in
Reported by a individual with unspecified qualification from France on 2012-07-19
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Ribavirin
Dosage: 1000 mg, qw
Indication: Hepatitis C
Start date: 2012-03-27
Viraferonpeg
Dosage: 100 microgram, qw
Indication: Hepatitis C
Start date: 2012-03-27
Possible Ribavirin side effects in
Reported by a individual with unspecified qualification from France on 2012-07-17
Patient:
Reactions: Hepatic Neoplasm Malignant
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ribavirin
Dosage: 400 mg, qd
Indication: Hepatitis C
Start date: 2011-09-14
End date: 2012-02-26
Victrelis
Dosage: 600 mg, qd
Indication: Hepatitis C
Start date: 2011-09-14
End date: 2012-02-26
Viraferonpeg
Dosage: 80 a?g, qw
Indication: Hepatitis C
Start date: 2011-09-13
End date: 2012-02-26
Other drugs received by patient: Neorecormon
Possible Ribavirin side effects in 43 year old male
Reported by a physician from United Kingdom on 2012-07-17
Patient: 43 year old male, weighing 68.0 kg (149.6 pounds)
Reactions: Hypoxic-Ischaemic Encephalopathy, Bronchopneumonia, Cardiac Arrest
Adverse event resulted in: death
Drug(s) suspected as cause:
Incivo
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-18
End date: 2012-04-20
Pegasys
Indication: Hepatitis C
Start date: 2012-04-18
End date: 2012-04-20
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-18
Other drugs received by patient: Albuterol Sulate; Omeprazole; Dihydrocodeine Bitartrate INJ; Beclomethasone Dipropionate; Diazepam
Page 1 Next >>
|